Cargando…
单中心181例广泛期小细胞肺癌的二线化疗及生存分析
BACKGROUND AND OBJECTIVE: Small cell lung cancer (SCLC) is the most malignant neuroendocrine tumor and sensitive to chemotherapy and radiotherapy. However, most patients who receive first-line chemotherapy will relapse within one to two years. Once recurrent, it indicates poor prognosis. Currently,...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000619/ https://www.ncbi.nlm.nih.gov/pubmed/24229622 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.02 |